vs

Side-by-side financial comparison of CLARIVATE PLC (CLVT) and Sylvamo Corp (SLVM). Click either name above to swap in a different company.

Sylvamo Corp is the larger business by last-quarter revenue ($890.0M vs $585.5M, roughly 1.5× CLARIVATE PLC). Sylvamo Corp runs the higher net margin — 3.7% vs -6.9%, a 10.6% gap on every dollar of revenue. On growth, CLARIVATE PLC posted the faster year-over-year revenue change (-1.4% vs -8.2%). CLARIVATE PLC produced more free cash flow last quarter ($78.9M vs $38.0M). Over the past eight quarters, Sylvamo Corp's revenue compounded faster (-0.8% CAGR vs -5.1%).

Clarivate Plc is a British-American publicly traded analytics company that operates a collection of subscription-based services, in the areas of bibliometrics and scientometrics; business and market intelligence, and competitive profiling for pharmacy and biotech, patents, and regulatory compliance; trademark protection, and domain and brand protection. Clarivate calculates the impact factor of scientific journals, using data from its Web of Science product family, that also includes services...

Sylvamo Corp is a leading global manufacturer of sustainable paper and pulp products. Its core offerings include uncoated printing paper, packaging paper, and market pulp, serving office supplies, publishing, commercial printing, and packaging segments across North America, Europe, and Latin America.

CLVT vs SLVM — Head-to-Head

Bigger by revenue
SLVM
SLVM
1.5× larger
SLVM
$890.0M
$585.5M
CLVT
Growing faster (revenue YoY)
CLVT
CLVT
+6.9% gap
CLVT
-1.4%
-8.2%
SLVM
Higher net margin
SLVM
SLVM
10.6% more per $
SLVM
3.7%
-6.9%
CLVT
More free cash flow
CLVT
CLVT
$40.9M more FCF
CLVT
$78.9M
$38.0M
SLVM
Faster 2-yr revenue CAGR
SLVM
SLVM
Annualised
SLVM
-0.8%
-5.1%
CLVT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLVT
CLVT
SLVM
SLVM
Revenue
$585.5M
$890.0M
Net Profit
$-40.2M
$33.0M
Gross Margin
67.2%
Operating Margin
8.9%
Net Margin
-6.9%
3.7%
Revenue YoY
-1.4%
-8.2%
Net Profit YoY
-163.1%
-59.3%
EPS (diluted)
$-0.06
$0.81

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLVT
CLVT
SLVM
SLVM
Q1 26
$585.5M
Q4 25
$617.0M
$890.0M
Q3 25
$623.1M
$846.0M
Q2 25
$621.4M
$794.0M
Q1 25
$593.7M
$821.0M
Q4 24
$663.0M
$970.0M
Q3 24
$622.2M
$965.0M
Q2 24
$650.3M
$933.0M
Net Profit
CLVT
CLVT
SLVM
SLVM
Q1 26
$-40.2M
Q4 25
$3.1M
$33.0M
Q3 25
$-28.3M
$57.0M
Q2 25
$-72.0M
$15.0M
Q1 25
$-103.9M
$27.0M
Q4 24
$-191.8M
$81.0M
Q3 24
$-65.6M
$95.0M
Q2 24
$-304.3M
$83.0M
Gross Margin
CLVT
CLVT
SLVM
SLVM
Q1 26
67.2%
Q4 25
66.8%
Q3 25
65.0%
Q2 25
67.2%
Q1 25
65.1%
Q4 24
65.7%
Q3 24
66.2%
Q2 24
67.2%
Operating Margin
CLVT
CLVT
SLVM
SLVM
Q1 26
Q4 25
6.7%
8.9%
Q3 25
7.1%
11.6%
Q2 25
1.1%
3.8%
Q1 25
-3.5%
5.4%
Q4 24
-9.4%
11.2%
Q3 24
3.5%
15.5%
Q2 24
-36.9%
13.1%
Net Margin
CLVT
CLVT
SLVM
SLVM
Q1 26
-6.9%
Q4 25
0.5%
3.7%
Q3 25
-4.5%
6.7%
Q2 25
-11.6%
1.9%
Q1 25
-17.5%
3.3%
Q4 24
-28.9%
8.4%
Q3 24
-10.5%
9.8%
Q2 24
-46.8%
8.9%
EPS (diluted)
CLVT
CLVT
SLVM
SLVM
Q1 26
$-0.06
Q4 25
$0.00
$0.81
Q3 25
$-0.04
$1.41
Q2 25
$-0.11
$0.37
Q1 25
$-0.15
$0.65
Q4 24
$-0.27
$1.91
Q3 24
$-0.09
$2.27
Q2 24
$-0.46
$1.98

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLVT
CLVT
SLVM
SLVM
Cash + ST InvestmentsLiquidity on hand
$198.0M
Total DebtLower is stronger
$4.3B
$763.0M
Stockholders' EquityBook value
$4.8B
$966.0M
Total Assets
$10.9B
$2.8B
Debt / EquityLower = less leverage
0.89×
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLVT
CLVT
SLVM
SLVM
Q1 26
Q4 25
$329.2M
$198.0M
Q3 25
$318.7M
$146.0M
Q2 25
$362.6M
$183.0M
Q1 25
$354.0M
$220.0M
Q4 24
$295.2M
$309.0M
Q3 24
$388.5M
$414.0M
Q2 24
$376.4M
$213.0M
Total Debt
CLVT
CLVT
SLVM
SLVM
Q1 26
$4.3B
Q4 25
$4.3B
$763.0M
Q3 25
$4.4B
$778.0M
Q2 25
$4.5B
$767.0M
Q1 25
$4.5B
$794.0M
Q4 24
$4.5B
$782.0M
Q3 24
$4.6B
$883.0M
Q2 24
$4.6B
$894.0M
Stockholders' Equity
CLVT
CLVT
SLVM
SLVM
Q1 26
$4.8B
Q4 25
$4.8B
$966.0M
Q3 25
$4.9B
$977.0M
Q2 25
$5.0B
$959.0M
Q1 25
$5.0B
$908.0M
Q4 24
$5.1B
$847.0M
Q3 24
$5.5B
$937.0M
Q2 24
$5.6B
$830.0M
Total Assets
CLVT
CLVT
SLVM
SLVM
Q1 26
$10.9B
Q4 25
$11.1B
$2.8B
Q3 25
$11.2B
$2.7B
Q2 25
$11.4B
$2.7B
Q1 25
$11.5B
$2.6B
Q4 24
$11.5B
$2.6B
Q3 24
$12.0B
$2.9B
Q2 24
$12.1B
$2.7B
Debt / Equity
CLVT
CLVT
SLVM
SLVM
Q1 26
0.89×
Q4 25
0.89×
0.79×
Q3 25
0.90×
0.80×
Q2 25
0.90×
0.80×
Q1 25
0.90×
0.87×
Q4 24
0.88×
0.92×
Q3 24
0.84×
0.94×
Q2 24
0.83×
1.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLVT
CLVT
SLVM
SLVM
Operating Cash FlowLast quarter
$134.7M
$94.0M
Free Cash FlowOCF − Capex
$78.9M
$38.0M
FCF MarginFCF / Revenue
13.5%
4.3%
Capex IntensityCapex / Revenue
9.5%
6.3%
Cash ConversionOCF / Net Profit
2.85×
TTM Free Cash FlowTrailing 4 quarters
$333.9M
$44.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLVT
CLVT
SLVM
SLVM
Q1 26
$134.7M
Q4 25
$159.9M
$94.0M
Q3 25
$181.1M
$87.0M
Q2 25
$116.3M
$64.0M
Q1 25
$171.2M
$23.0M
Q4 24
$141.3M
$164.0M
Q3 24
$202.9M
$163.0M
Q2 24
$126.2M
$115.0M
Free Cash Flow
CLVT
CLVT
SLVM
SLVM
Q1 26
$78.9M
Q4 25
$89.2M
$38.0M
Q3 25
$115.5M
$33.0M
Q2 25
$50.3M
$-2.0M
Q1 25
$110.3M
$-25.0M
Q4 24
$59.1M
$100.0M
Q3 24
$126.3M
$119.0M
Q2 24
$60.3M
$62.0M
FCF Margin
CLVT
CLVT
SLVM
SLVM
Q1 26
13.5%
Q4 25
14.5%
4.3%
Q3 25
18.5%
3.9%
Q2 25
8.1%
-0.3%
Q1 25
18.6%
-3.0%
Q4 24
8.9%
10.3%
Q3 24
20.3%
12.3%
Q2 24
9.3%
6.6%
Capex Intensity
CLVT
CLVT
SLVM
SLVM
Q1 26
9.5%
Q4 25
11.5%
6.3%
Q3 25
10.5%
6.4%
Q2 25
10.6%
8.3%
Q1 25
10.3%
5.8%
Q4 24
12.4%
6.6%
Q3 24
12.3%
4.6%
Q2 24
10.1%
5.7%
Cash Conversion
CLVT
CLVT
SLVM
SLVM
Q1 26
Q4 25
51.58×
2.85×
Q3 25
1.53×
Q2 25
4.27×
Q1 25
0.85×
Q4 24
2.02×
Q3 24
1.72×
Q2 24
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLVT
CLVT

Subscription$397.5M68%
Re-occurring$108.6M19%
Transactional$79.4M14%

SLVM
SLVM

Segment breakdown not available.

Related Comparisons